Postoperative Bio-Chemoradiotherapy Using Cetuximab and Docetaxel in Patients With Cis-Platinum-Intolerant Core High-Risk Head and Neck Cancer: Protocol of a Phase 2 Nonrandomized Clinical Trial.
JMIR Res Protoc
; 7(8): e11003, 2018 Aug 23.
Article
in En
| MEDLINE
| ID: mdl-30139721
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Language:
En
Journal:
JMIR Res Protoc
Year:
2018
Document type:
Article
Affiliation country:
Country of publication: